The authors previously reported a new syndrome, angiotensin-converting enzyme dysfunction syndrome (ACEDS), which is clinically characterized by mild systemic hypertension, a hypokalemic alkalosis, and hyperreninism with a high concentration of angiotensin-I (ANG-I), a normal angiotensin-II (ANG-II) value, and a normal aldosterone level. In the present study, they investigated the diagnosis and differentiation of diseases concomitant with hyperreninism, such as ACEDS, Bartter's syndrome, familial periodic paralysis, and renovascular hypertension treated with captopril for two months, and discussed the pathogenesis of ACEDS.
Get full access to this article
View all access options for this article.
References
1.
Davis JO, Freeman RH: Mechanisms regulating renin release. Physiol Rev56:1-56, 1976.
2.
Keeton TK, Cambel WB: The pharmacological alterations of renin release. Pharmacol Rev32:81-227, 1980.
3.
Umeki S., Ohga R., Ono S., Yasuda T., Morimoto K., Terao A.: Angiotensin I level and sporadic hypokalemic periodic paralysis. Arch Intern Med146:1956-1960, 1986 .
4.
Bartter FC, Pronove P., Gill JR, et al: Hyperplasia of the juxtaglomerular complex with hyperaldosteronism and hypokalemic alkalosis. Am J Med33:811-828, 1962.
5.
Gill JR, Bartter FC: Evidence for a prostaglandin-independent defect in chloride reabsorption in the loop of Henle as a proximal cause of Bartter's syndrome. Am J Med65:766-772, 1978.
6.
Zierler KL, Andres R.: Movement of potassium into skeletal muscle during spontaneous attack in family periodic paralysis. J Clin Invet36:730-737, 1957.
7.
Pearson CM: The periodic paralysis: Differential features and pathological observations in permanent myopathic weakness. Brain87:341-354, 1964.
8.
Takeda R., Morimoto S., Uchida K., et al: Changes in plasma renin activity and plasma aldosterone in the induced paralytic attack of thyrotoxic periodic paralysis. Acta Endocrinol82:715-727, 1976.
9.
Laragh JH, Sealey JE, Sommers SC: Patterns of adrenal secretion and urinary excretion of aldosterone and plasma renin activity in normal and hypertensive subjects. Circ Res18(1):158-174, 1966.
10.
Laragh JH: Vasoconstrictor-volume analysis for understanding and treating hypertension: The use of renin and aldosterone profiles. Am J Med55:261-274, 1973.
11.
Kurtzman NA , Pillay Vkg, Roers PW, et al: Renal vascular hypertension and low plasma renin activity. Interrelationship of volume and renin in the pathogenesis of hypertension. Arch Intern Med133:195-199, 1974.
12.
Hollenberg NK: Medical therapy of renovascular hypertension: Efficacy and safety of captopril in 269 patients. Cardiovasc Rev Rep4:852-879, 1983.
13.
Abe K., Ito T., Sato M., et al: Role of prostaglandin in antihypertensive mechanism of captopril in low renin hypertension. Clin Sci59(Suppl 6):141s-144s, 1980.
14.
Itskovitz HD , McGriff JC: Hormonal regulations of the renal circulation . In: Hypertension XXII: Peptides, Lipids, Electrolytes, and Hypertension, ed. by Hunt JC. Circ Res34 & 35(Suppl 1):65-73, 1974.
15.
Webster ME, Gilmore JP: Influence of kallidin-10 on renal function. Am J Med206:714-718, 1964.
16.
Nasjletti A. , Colina-Chourio J., McGriff JC: Disappearance of bradykinin in the renal circulation of dogs. Effects of kininase inhibition. Circ Res37:59-65, 1973.
17.
Rocha AS, Kokko JP: Sodium chloride and water transport in the medullary thick ascending limb of Henle. Evidence for active chloride transport. J Clin Invest52:612-623, 1973.
18.
Weber PC, Larson C., Anggard E., et al: Stimulation of renin release from rabbit renal cortex by arachidonic acid and prostaglandin exdoperoxides. Circ Res39:868-874, 1976.
19.
Stokes JB, Kokko JP: Inhibition of sodium transport by prostaglandin E2 across the isolated, perfused rabbit collecting tubule. J Clin Invest59:1099-1104, 1977.
20.
Gill JRJr: Bartter's syndrome. Ann Rev Med31:405-419, 1980.
